TAMPA, Fla., Dec. 2, 2004 (PRIMEZONE) -- Rx Processing Corporation (Pink Sheets:RXPC), one of the nation's leading sources of affordable prescription medications, announces that LabPass Solutions will be offering free PSA and Thyroid tests to Rx Processing Corporation's customers at the Company's storefront locations.
LabPass Solutions has agreed to provide free prostate cancer testing and free thyroid testing, along with access to many other deeply discounted diagnostic tests, for Rx Processing and its storefronts through the end of 2004. This partnership allows both Companies to expand their product offerings, opening additional revenue channels. LabPass Solutions provides access to over 1000 diagnostic tests that include heart disease risk assessment, cancer detection and several other wellness tests that provide early detection. LabPass provides commercial drug and blood testing for DOT/FAA. They offer custody legal drug screening program applications, and instant drug screening kits for private testing.
Recently the Company signed a distribution agreement to provide LabPass Solutions access to Rx Processing's affordable mail-order prescription medications. This agreement establishes Rx Processing Corporation as the new mail-order prescription-processing center for LabPass Solutions for the next two years. Rx Processing works with licensed pharmacies both domestically and internationally, to provide top-quality lower-cost name brand and generic drugs to consumers. A cost savings of up to 84% is realized by filling prescriptions with either discounted U.S. or Canadian government-approved drugs.
According to LabPass Solutions President, Peter Matuch, "We at LabPass look forward to a mutually productive relationship with RXPC and are happy to be able to offer these valuable tests to the people of RXPC. At LabPass we believe business is about people. Here we try to take the approach of 'one customer at a time' ensuring quality."
Peter Fiorillo, President of Rx Processing, comments, "With affiliates like LabPass Solutions, Americans can clearly reduce their costs for healthcare services. These savings are critical for the millions of Americans that lack access to diagnostic testing and prescription drug coverage."
Rx Processing is rapidly becoming a market leader in providing prescription drugs to U.S. Citizens, corporations, unions, and prescription benefit plans through licensed pharmacies in the United States and Canada. The Company provides access to over 1,500 approved name brand and generic medications ready for distribution in the U.S. market through its Company owned and operated storefront locations and over 130 affiliated storefronts. By utilizing Rx Processing, U.S. citizens can save up to 84% on their daily prescriptions. These reduced cost medications are available at the Company's affiliate retail storefronts and information about the company can be found at http://www.rxprocessingcorp.com
Safe Harbor Statement
All statements other than statements of historical fact included in this press release are ``forward-looking statements.'' The forward-looking statements, including statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e., future operational results and sales) are subject to assumptions and beliefs based on current information known to the Company and factors that are subject to uncertainties, risk and other influences, which are outside the Company's control, and may yield results differing materially from those anticipated.